Read about 56 natural beauty products in this sheknows.com article.
Clinical Research Trials Basics
Read about the basics of clinical research trials on the National Institutes of Health website.
Dermatology Acne: Causes, Diagnosis and How to Get Rid of Acne
Read more about the causes, diagnosis and how to get rid of acne in this Medical News Today article.
Take Control of Your Rosacea
Read more about the types of Rosacea and the factors that contribute to Rosacea.
Top 30 Skin Clearing Foods
Think spots are something just teenagers get? Think again. Around 20 per cent of women suffer from acne well into their 20s and 30s, which can be caused by anything from stress to hormone fluctuations and more. Read the full article here.
The 10 Commandments of Clear Skin
Interested in clear skin? Check out Allure’s 10 Commandment of Clear Skin. Click here to read.
Mirvaso works for Lupus, Dermatomyositis and Pityriasis Rubra Pilaris
The off label use for Mirvaso gel is becoming better documented with the publication of a recent paper suggesting that Mirvaso was well tolerated by and offered good benefits to sufferers of Systemic Lupus, Dermatomyositis and Pityriasis Rubra Pilaris. These conditions share a symptom – erythema, that is the appearance of a red face. Only 3 patients… Read More
Research Does Not End at Medicines Approval
Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA). In fact, that’s when post-approval research and monitoring begin and they help all health care stakeholders, including physicians and patients, to better understand the full value of… Read More
7 FUNDAMENTAL QUESTIONS TO ASK ABOUT CLINICAL TRIALS
No matter if clinical trials are sponsored by the industry or government, they have the goal to improve or discover completely new ways for treating diseases. But most of all, researches are capable of dictating the advancement of medicine and healthcare. There are millions of volunteers who realize how important for the sector and humans… Read More
Eli Lilly’s Ixekizumab Positive in Plaque Psoriasis Studies
Eli Lilly and Company LLY announced encouraging results from two phase III studies, UNCOVER-2 and UNCOVER-3, on ixekizumab for the treatment of patients with moderate-to-severe plaque psoriasis. This double-blind, multicenter, phase III studies evaluated ixekizumab, in comparison to Amgen Inc.’s AMGN Enbrel (etanercept) or placebo, in patients with moderate-to-severe plaque psoriasis. In both the studies,… Read More